Difficulty: Medium
Average Score: 68%
Practice
Incorporation of vasoconstrictor substance in a solution of a drug to be injected subcutaneously retards absorption. This principal is utilized in combination of
Correct answer
A
Rationale
The correct answer is A) Epinephrine with local anesthetics. The rationale behind incorporating a vasoconstrictor substance like epinephrine in a solution of a drug to be injected subcutaneously is to constrict blood vessels at the injection site. This constriction reduces blood flow, which in turn slows down the absorption of the drug into the bloodstream.
In the context of local anesthetics, adding epinephrine prolongs the duration of anesthesia by reducing systemic absorption of the anesthetic agent. This allows for a more localized and effective numbing effect, as the drug stays concentrated in the intended area for a longer period of time.
Regarding why the other options are incorrect:
- Option B) Epinephrine with I.V. glucose doesn't make sense in this context as glucose is not typically injected subcutaneously and does not require vasoconstriction for absorption.
- Option C) With vaccines, vasoconstriction is not typically utilized to slow absorption but rather adjuvants or delivery systems are used to enhance the immune response.
- Option D) With insulin, vasoconstriction would actually be counterproductive as the goal is to facilitate rapid absorption to regulate blood sugar levels.
Understanding the rationale behind incorporating vasoconstrictors in drug formulations is crucial for healthcare professionals to optimize drug delivery and efficacy while minimizing systemic effects. This knowledge helps in safe and effective administration of medications, ensuring patient comfort and treatment success.
In the context of local anesthetics, adding epinephrine prolongs the duration of anesthesia by reducing systemic absorption of the anesthetic agent. This allows for a more localized and effective numbing effect, as the drug stays concentrated in the intended area for a longer period of time.
Regarding why the other options are incorrect:
- Option B) Epinephrine with I.V. glucose doesn't make sense in this context as glucose is not typically injected subcutaneously and does not require vasoconstriction for absorption.
- Option C) With vaccines, vasoconstriction is not typically utilized to slow absorption but rather adjuvants or delivery systems are used to enhance the immune response.
- Option D) With insulin, vasoconstriction would actually be counterproductive as the goal is to facilitate rapid absorption to regulate blood sugar levels.
Understanding the rationale behind incorporating vasoconstrictors in drug formulations is crucial for healthcare professionals to optimize drug delivery and efficacy while minimizing systemic effects. This knowledge helps in safe and effective administration of medications, ensuring patient comfort and treatment success.